|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Advances in male contraception显示文摘 | Page ST Amory JK Bremner WJ | 2008 | Endocr Rev2008，29，4： | 1 |
| 2 | Intratesticular androgens and spermatogenesis during severegonadotropin suppression induced by male hormonal contraceptivetreatment 显示文摘 | PAGE ST KALHORN TF BREMNER WJ ANA WALT BD etal | 2007 | / Androl y2007，2，5： | 1 |
| 3 | Low sex hormone-binding globulin,total testosterone,and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men显示文摘 | Kupelian V Page ST Araujo AB | 2009 | J Clin Endocrinol Metab2009，9，1： | 1 |
| 4 | Testosterone administration suppresses adiponectin levels in men 显示文摘 | Page ST Herbst KL Amory JK | 2005 | Androl2005，26，8： | 1 |
| 5 | Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression:therapeutic implications for castration-resistant prostate cancer显示文摘 | Mostaghel EA Page ST Lin DW | 2007 | Cancer Res2007，67，： | 1 |
| 6 | Treatment of male infertility secondary to morbid obesity显示文摘 | Roth MY Amory J K Page ST | 2008 | Nat Clin Pract Endocrinol Metab2008，4，7： | 1 |
| 7 | Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression:therapeutic implications for castration-resistant prostate cancer显示文摘 | Mostaghel EA Page ST Lin DW | | 0，，10： | 1 |
| 8 | Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer显示文摘 | Mostaghel EA Page ST Lin DW | 2007 | CancerRes2007，67，10： | 1 |
| 9 | Reproductive endocrinology: Late-onset hypogonadism: evidence for diagnostic criteria 显示文摘 | Page ST | 2010 | Nat Rev Endocrino2010，6，11： | 1 |
| 10 | Intraprostatie androgens and androgen -regulated gene expression persist after testosterone suppression : therapeutic implications for castration - resistant pros- tate eaneer显示文摘 | Mostaghel EA Page ST Lin DW | 2007 | Caneer Res2007，67，10： | 1 |
| 11 | Efficacy of modified constraint- induced movement therapy in chronic stroke: a single-blinded randomized controlled trial 显示文摘 | Page SJ Si st o S Levine P | 2004 | Arch Phys Med Rehabil2004，85，： | 1 |
| 12 | The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease:longitudinal results from the Massachusetts Male Ageing Study显示文摘 | Page ST Kupelian V Brernner WJ | 2006 | Clin Endocrinol(Oxf)2006，65，3： | 1 |
| 13 | Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T 显示文摘 | Page ST Amory JK Bowman FD | 2005 | J Clin Endocrinol Metab2005，90，3： | 1 |
| 14 | Low sex hormone binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men 显示文摘 | Kupelian V Page ST Araujo AB | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 15 | High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia显示文摘AIM To evaluate the importance of the CD34+CD38-cell population when compared to the CD34+CD38+/low and CD34+CD38+/high leukemic cell sub-populations and to determine its correlations with leukemia characteristics and known prognostic factors, as well as with response to therapy and survival.METHODS Two hundred bone marrow samples were obtained at diagnosis from 200 consecutive patients with newly diagnosed acute myeloid leukemia(AML) were studied between September 2008 and December 2010 at our Institution(Hematology Department, Lyon, France). The CD34/CD38 cell profile was analyzed by multiparameter flowcytometry approach using 8 C panels and FACS CANTO and Diva software(BD Bioscience).RESULTS We analyzed CD34 and CD38 expression in bone marrow samples of 200 AML patients at diagnosis, and investigated the prognostic value of the most immature CD34+CD38-population. Using a cut-off value of 1% of CD34+CD38-from total 'bulk leukemic cells' we found that a high(> 1%) level of CD34+CD38-blasts at diagnosis was correlated with advanced age, adverse cytogenetics as well as with a lower rate of complete response after induction and shorter disease-free survival. In a multivariate analysis considering age, leukocytosis, the % of CD34+ blasts cells and the standardized cytogenetic and molecular risk subgroups, a percentage of CD34+CD38-leukemic cells > 1% was an independent predictor of DFS [HR = 2.8(1.02-7.73), P = 0.04] and OS [HR = 2.65(1.09-6.43), P = 0.03].CONCLUSION Taken together, these results show that a CD34/CD38 'backbone' for leukemic cell analysis by multicolour flowcytometry at diagnosis provides useful prognostic information. | Adriana Plesa Charles Dumontet Eve Mattei Ines Tagoug Sandrine Hayette Pierre Sujobert Isabelle Tigaud Marie Pierre Pages Youcef Chelghoum Fiorenza Baracco Helene Labussierre Sophie Ducastelle Etienne Paubelle Franck Emmanuel Nicolini Mohamed Elhamri Lydia Campos Claudiu Plesa Stéphane Morisset Gilles Salles Yves Bertrand Mauricette Michallet Xavier Thomas | 2017 | World Journal of Stem Cells2017，9，12： | 1 |
| 16 | Persistent intraprostatic androgen concentrations after medical castration in healthy men 显示文摘 | PAGE ST LIN DW MOSTAGHEL EA | 2006 | J Clin Endocrinol Metab2006，91，10： | 1 |
| 17 | Treatment of male infertility secondary to morbid obesity显示文摘 | Roth MY Amory JK Page ST | 2008 | Nat Clin Pract Endocrinol Metab2008，4，7： | 1 |
| 18 | Exogenous testosterone (T) alone or with finasteride increases physical performance,grip strength,and lean body mass in older men with low serum T显示文摘 | Page ST Amory JK Bowman FD | 2005 | J Clin Endocrinol Metab2005，90，3： | 1 |
| 19 | Reliability of point of--care capillary blood glucose measurements in the critical value range显示文摘 | Schifman RB Nguyen TT Page ST | 2014 | Arch Pathol Lab Med2014，138，7： | 1 |
| 20 | Effect of medical castration on CD4+ CD25+T cells, CD8+T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites显示文摘 | Page ST Plymate SR Bremner WJ | 2006 | Am J Physiol Endocrinol Metab2006，290，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员